(Q34038018)

30 July 2017

title

Chronic toxicity studies with vigabatrin, a GABA-transaminase inhibitor (English)

1 reference

30 July 2017

0 references

J P Gibson

1

1 reference

30 July 2017

J T Yarrington

2

1 reference

30 July 2017

D E Loudy

3

1 reference

30 July 2017

C G Gerbig

4

1 reference

30 July 2017

G H Hurst

5

1 reference

30 July 2017

J W Newberne

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 1990

1 reference

30 July 2017

published in

Toxicologic Pathology

1 reference

30 July 2017

volume

18

1 reference

30 July 2017

issue

2

1 reference

30 July 2017

page(s)

225-238

1 reference

The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

The relationship between GABA concentrations in brain and cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

Analysis of the major amino acids of rat brain after in vivo inhibition of GABA transaminase by ethanolamine O-sulphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

gamma-Vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

Hexachlorophene effects on the rat brain: study of high doses by light and electron microscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

4-amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

Double-blind, placebo-controlled study of vigabatrin (gamma-vinyl GABA) in drug-resistant epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

Blockade of epileptic responses in the photosensitive baboon, Papio papio, by two irreversible inhibitors of GABA-transaminase, ?-acetylenic GABA (4-amino-hex-5-ynoic acid) and ?-vinyl GABA (4-amino-hex-5-enoic acid)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

The pharmacology of GABA-transaminase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

Vigabatrin: no microvacuoles in a human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

gamma-Vinyl GABA: effects of chronic administration on the metabolism of GABA and other amino compounds in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

Double-blind study of gamma-vinyl GABA in patients with refractory epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

Psychophysiological and psychometric studies after manipulating the GABA system by vigabatrin, a GABA-transaminase inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

Vigabatrin in the treatment of epilepsy: a double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F019262339001800201

10.1177/019262339001800201

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference